木瓜直播

News and commentary from the endocrinology world

In WeightWatchers study, 45% decreased their alcohol use after initiating a weight-loss drug

But how to achieve equitable use remains "complicated," says expert

Balancing aspiration risk with the consequences of medication discontinuation

Addition of GLP-1 drugs led to an even greater reduction

News and commentary from the endocrinology world

Most are eligible for weight management indication

In the third year, 88% of patients could go 12 weeks or longer with 8-mg dose

SUMMIT trial able to show clinical benefit beyond quality-of-life improvement

Also in TTHealthWatch: frailty as a predictor of dementia

Real-world data suggested semaglutide, liraglutide reduced AUD-related hospitalizations

News and commentary from the endocrinology world

Also in TTHealthWatch: early sugar exposure, hypertension, and diabetes

Labels now caution about pulmonary aspiration risk